Adoptive Cell Therapy
Screening Platform
Screening Platform is flagged as a low confidence because it has an active early-phase oncology cell-therapy trial at GlaxoSmithKline, with a unlinked patent signal linked through public patent-search heuristics. Manual review is still required.
Phase2 · Terminated
View asset